Skip to main content
Livermore
Livermore
ZHEN

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Abeona Therapeutics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ABEO: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders4856+8
Shares14.1M14.4M+308.7K (+2.2%)
Value$70.8M$104.7M+$33.9M (+47.9%)

New holders (15)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ABEO in Q1 2024
InstitutionSharesValue% of portfolio
Laurion Capital Management LP646,830$4.69M0.13%
Goldman Sachs Group Inc171,533$1.24M0.00%
Man Group plc73,824$535.2K0.00%
HRT Financial LP69,051$500.0K0.00%
Gsa Capital Partners LLP24,561$178.0K0.01%
Balyasny Asset Management LLC19,026$137.9K0.00%
Engineers Gate Manager LP17,760$128.8K0.00%
Creative Planning15,005$108.8K0.00%
Palumbo Wealth Management LLC14,368$104.2K0.05%
Acadian Asset Management LLC12,634$91.0K0.00%
Omers Administration Corp12,400$89.9K0.00%
UBS Group AG10,457$75.8K0.00%
Lazard Asset Management LLC1,124$7.00K0.00%
FMR LLC40$2900.00%
Macquarie Group Ltd760$60.00%

Sold out (7)

Institutions that held Abeona Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ABEO in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
AIGH Capital Management LLC787,769$3.95M
Point72 Asset Management, L.P.760,870$3.81M
Knott David M Jr198,300$993.0K
Worth Venture Partners, LLC196,439$984.2K
EAM Investors, LLC97,809$490.0K
Two Sigma Investments, LP56,948$285.3K
Northwestern Mutual Wealth Management Co60$301